Currently, there are very few treatment options for those with Alzheimer’s disease (AD). Clinical trials are the only way for new treatments to be developed that can prevent progression of the disease. Clinical trials also help us learn more about AD. At the Byrd Institute, we are involved in several research studies, adding new studies regularly. We offer a range of participation options including prevention studies for older people without memory loss and studies that include treatment of mild cognitive impairment (MCI) and mild to moderate AD. Some of our trials are observation-only, while others involve oral medications, injections, or infusions. Additionally, many trials include special blood tests, cognitive testing, and brain imaging (MRIs and PET scans). Below is a list of our current study opportunities.

For Individuals with Memory Loss

• A multi-year observational study involving cognitive testing and neuroimaging, which may help to learn more about Alzheimer’s disease. 
• A 72-week trial investigating two doses of an oral treatment which may improve cognition and function in patients with early Alzheimer’s disease. This study is for patients 50-85 years old with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s disease

For Individuals without Memory Loss

• Check back often for new trials.

For Individuals with Memory Loss

• A 26-week trial investigating an oral treatment which may improve cognition and modify disease progression in patients with Alzheimer’s disease. This study is for patients 55-85 years old with mild to moderate Alzheimer’s disease.

For Individuals without Memory Loss

• Check back often for new trials.

We always have new trials just around the corner. Please check back with us for updates!

For more information about our clinical research, contact:

Jenny Echevarria
jenny8@usf.edu
(813) 396-9695 

Anna Sladky 
asladky@usf.edu
(813) 974-4904